GangadharRaoMalasanaMD

PubMed

• 3 citations
  Transcatheter Aortic Valve Replacement in Dextrocardia With Situs Inversus
  Gangadhar Rao Malasana, Magdalena Zeglin, Russell McElveen
  JACC. Case Reports. 2020-06-01
• 19 citations
  A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation.
  Gangadhar Malasana, John D. Day, J. Peter Weiss, Brian G. Crandall, L R N Tami Bair
  Journal of Cardiovascular Electrophysiology. 2011-07-01
• 9 citations
  Underevaluation of cardiovascular risk factors in patients with nonaccidental falls.
  Marcos Daccarett, Michele Brignole, Gangadhar R. Malasana, Randall P. Sherwood, Tawni L. Jetter
  Journal of Primary Care & Community Health. 2011-05-17

Journal Articles

• Atrial Fibrillation in Hypertrophic Obstructive Cardiomyopathy - Antiarrhythmics, ablation and more!  
  Malasana Gangadhar; Day John D.; Bunch T. Jared., JAFIB, 10/1/2009
• Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase  
  JW Galliford, Malasana Gangadhar, K Farrington, Nephrol Dial Transplant, 9/1/2005

Abstracts/Posters

• A Novel Ungated Cardiac Magnetic Resonance Perfusion Protocol for the Detection of Significant Single and Multivessel Coronary Disease in Patients with Atrial Fibrilla...
  Lowell Chang, Promporn Suksaranjit, Gangadhar Malasana, Allen Rassa, Ganeshsharma Adluru, Krishna Velagapudi, Devarvrat Likhite, Alexis Harrison, Brent Wilson, Christo..., American College of Cardiology, 3/29/2014
• High prevalence of right ventricular dysfunction in ICD patients with shocks: A potential new predictor in risk stratification
  Malasana Gangadhar, Kuppahally Suman, Daccarett Marcos , Wasmund S, Litwin S, Hamdan Mohamed, Heart Rhythm Society, 5/13/2010
• The magnitude of the Faint and fall in Utah: A first step towards the creation of cost-effective diagnostic approaches
  Malasana Gangadhar, Brignole Michele, Daccarett Marcos, Randall Sherwood, Hamdan, Heart Rhythm Society, 5/13/2010
• Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase
  JW Galliford, Malasana Gangadhar, K Farrington, British Renal Society; Nephrol Dial Transplant, Harrogate, United Kingdom, 5/3/2006
• Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase
  JW Galliford, Malasana Gangadhar, K Farrington, British Renal Society, 5/3/2006
• Join now to see all

Lectures

• Chronic Thromboembolic Pulmonary Hypertension 
  5/5/2014
• Coronary Angiography in cardiac arrest survivors 
  4/7/2014
• A Novel Ungated Cardiac Magnetic Resonance Perfusion Protocol for the Detection of Significant Single and Multivessel Coronary Disease in Patients with Atrial Fibrilla... 
  Washington, DC - 3/29/2014
• Management of Flail Mitral valve 
  10/7/2013
• Vulnerable Plaque – Role of non-invasive imaging 
  4/27/2013
• PC trial - Cardiology Journal club 
  11/1/2012
• Iron Overload Cardiomyopathy 
  8/13/2012
• Nuclear-Cath correlation 
  4/18/2012
• Constriction vs Restriction 
  3/14/2012
• Tricuspid Regurgitation, Forgotten valve 
  2/27/2012
• Refractory Cardiogenic shock 
  12/5/2011
• Atelectasis 
  4/21/2011
• Airway management in Pregnancy 
  1/13/2011
• Plastic Bronchitis 
  10/21/2010
• High prevalence of right ventricular dysfunction in ICD patients with shocks: A potential new predictor in risk stratification 
  Denver, CO - 5/13/2010
• The magnitude of the Faint and fall in Utah: A first step towards the creation of cost-effective diagnostic approaches 
  Denver, CO - 5/13/2010
• Join now to see all